NRx Pharmaceuticals received FDA approval for its preservative-free ketamine formulation ahead of the November 10, 2026 deadline. This new ketamine product contains no benzethonium chloride, a toxic preservative banned by the FDA, and is manufactured in the U.S. using modern technology. The approval addresses ketamine shortages and supports reshoring sterile injectable drug production to the U.S., benefiting patients and healthcare providers. NRx plans to supply American hospitals with this safer ketamine option primarily used for anesthesia and pain control.
NRx Pharmaceuticals' FDA approval of preservative-free ketamine provides context for health sector activity. For readers following health stocks, here is Pluang's market snapshot as of Oct 30, 2026 16:51 WIB: Of 150 priced health-sector US stocks tradable on Pluang, 73 rose and 70 fell today. Notable movers include INO at USD 0.81 (+5.17%), TAK at USD 21.00 (+4.95%), and AZN at USD 181.87 (+4.28%).
As Halloween approaches, MADD Canada warns against impaired driving caused by alcohol, cannabis, or drugs, which leads to hundreds of deaths and thousands of injuries annually in Canada. The organization urges people to plan safe transportation if co...
MADD Canada warns Canadians to avoid impaired driving during Halloween, emphasizing the risks of alcohol, cannabis, and drug-related crashes that cause deaths and injuries annually. The organization urges people to plan safe rides, watch for children...
Investec Bank Plc, acting as joint broker for SThree Plc, disclosed share transactions on October 29, 2026. The bank purchased and sold 49,799 ordinary shares of SThree Plc at prices ranging between 297.5 and 306.5 per share. No derivative or option ...
Investec Bank plc, acting as joint broker for Gamma Communications Plc, disclosed its share dealings on October 29, 2026. The bank purchased 218,193 ordinary shares at prices between 1091 and 1094 pence per share and sold 160,410 shares at prices bet...
Investec Bank Plc, acting as advisor and joint broker to Advanced Medical Solutions Group Plc, disclosed its share dealings on October 29, 2026. The bank purchased 10,640 ordinary shares at a price of 282.75 per share and sold 98 shares at 283 each. ...
